Gephardt, AZ’s Brennan on Innovation: What Is Our Moon Shot?

Will Chemical Engineers Save Pharma?

A Contrarian View of FDA: Bloated and Inefficient

Pfizer Drops Two Late-Stage Candidates, Citing Little Market Potential

Dangerous Documents101: When a Shredder Isn't Enough, There's a Preventive Course

Engineers Nail QbD in Philadelphia

Applying Modern Methods to Traditional Meds

"Heparin Was an Industry Wake-Up Call": A Star Turn by CDER's Janet Woodcock